Sunday, June 14, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result

Rolls-Royce Grounds a Hydrogen Milestone as Geopolitical Headwinds Rattle Aviation Sentiment

SiterGedge by SiterGedge
May 16, 2026
in Uncategorized
0
Rolls-Royce Stock
0
SHARES
21
VIEWS
Share on FacebookShare on Twitter

Rolls-Royce has delivered a genuine technological breakthrough—successfully running a Pearl-15 engine on 100% hydrogen at full takeoff thrust—only to see its shares punished by concerns that the US-Iran conflict will throttle the civil aviation recovery. The stock closed the week at €13.23, a 3.98% slide on Friday alone and a 6.12% weekly loss, leaving the equity nearly 17% below the all-time high of €15.92 set in late February.

The engineering achievement, reached with partner easyJet at NASA’s Stennis Space Center in Mississippi, saw a modified Pearl-15 gas turbine complete a simulated flight cycle from startup to landing using pure gaseous hydrogen. Chief engineer Adam Newman said the team has developed “the clearest understanding in the industry” of how hydrogen behaves inside a modern aero engine. The insights are already feeding into future programmes such as UltraFan, although Rolls-Royce acknowledges that commercial hydrogen-powered jets remain years away due to unresolved challenges in storage, infrastructure, airframe design, and certification.

Investors, however, have other priorities. The escalating conflict between the US and Iran has raised the spectre of kerosene shortages, route closures, and flight cancellations across Europe and the Middle East—a scenario that directly threatens Rolls-Royce’s aftermarket business, which is heavily tied to engine flying hours. The sell-off is not isolated: peers GE Aerospace and Safran have suffered comparable falls.

Operationally, the company has yet to see any deviation from its trajectory. Large engine flying hours rose 5% in the first quarter, reaching 115% of pre-pandemic levels, and management is targeting 115-120% for the full year. The 2026 guidance remains intact: an operating profit of £4.0-4.2 billion and free cash flow of £3.6-3.8 billion. Defence and Power Systems—the latter buoyed by demand for data-centre power supply—continue to build order books.

Should investors sell immediately? Or is it worth buying Rolls-Royce?

Analysts are holding their ground. Fourteen recommend buying the stock, and none advise selling. The average 12-month price target stands at 1,412.90 pence, with the most bullish forecast at 1,740 pence. Meanwhile, Rolls-Royce’s improving credit profile is supported by recent upgrades from Moody’s and Fitch, partly driven by the repayment of a €750 million bond from free cash flow. The group has also returned to the euro bond market to reinforce its liquidity buffer against a prolonged downturn.

Technically, the shares are caught in a precarious zone. They have slipped below both the 50-day and 100-day moving averages, clinging just above the 200-day line at €13.63. The relative strength index sits near 50, offering no clear directional signal. Chart watchers peg a critical support level at around 1,100 pence (equivalent to roughly €12.75); a double-bottom formation there could open a path back to the resistance near 1,210 pence. If that floor gives way, the psychological 1,000-pence mark comes into view.

For now, the hydrogen test gives the long-term narrative fresh weight, but the market is fixated on near-term risks. Rolls-Royce needs a de-escalation in the Middle East as much as it needs to keep investing in the technologies that will define the next era of flight. The next test is not on a test stand in Mississippi, but in the geopolitics of the Straits of Hormuz and the skies above Tel Aviv.

Ad

Rolls-Royce Stock: Buy or Sell?! New Rolls-Royce Analysis from June 14 delivers the answer:

The latest Rolls-Royce figures speak for themselves: Urgent action needed for Rolls-Royce investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from June 14.

Rolls-Royce: Buy or sell? Read more here...

Tags: Rolls Royce
SiterGedge

SiterGedge

Related Posts

Novo Nordisk Stock
Analysis

Novo Nordisk Sharpens Its Pipeline Edge as Longevity Pivot Takes Shape

June 14, 2026
BMW Stock
Automotive & E-Mobility

BMW Executive Puts Money on Recovery After Stock Plunge, as Electric M-Concept Unveiled at Le Mans

June 14, 2026
Uranium Energy Stock
Analysis

Uranium Energy’s $52 Million Quarter: No Revenue, a New Texas Mine, and a $794 Million Cushion

June 14, 2026
Next Post
Intel Stock

Intel's Shareholder Mandate and Apple's Limited Foundry Role: A Tale of Two Realities

Marvell Technology Stock

Marvell's Optical Ambition and Insider Moves Create a Tale of Two Narratives

Ocugen Stock

Ocugen’s Gene Therapy Candidates Race Toward FDA Filings, But the Market Isn’t Ready to Celebrate

Recommended

Novo Nordisk Stock

Novo Nordisk Bets on Oral Wegovy to Expand Weight-Loss Market Reach

5 months ago
Blackrock Stock

BlackRock’s Global Strategy: Dividend Payouts and Market Expansion

9 months ago
D-Wave Quantum Stock

D-Wave Quantum: A Story of High Ambition Amidst Financial Crosscurrents

3 months ago
Ooma Stock

Ooma Stock: A Clash Between Analyst Optimism and Insider Selling

9 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Netflix Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power Realty Income Robinhood Rocket Lab USA Salesforce Strategy Synopsys Take-Two Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics XRP
No Result
View All Result

Highlights

Ocugen Faces a Moment of Truth as Clinical Catalysts Collide With a 55% Plunge

Amazon’s Freight Gambit and Regulatory Headwinds Eclipse Prime Day Hype

OHB’s Record Backlog and a Shifting Shareholder Base Set the Stage for a Defining Summer

Germany’s Communities Feel the Squeeze as Labour Shortage Forecast Worsens by 1.3 Million

European Lithium Faces a Trio of Hurdles as Lithium Markets Show Signs of Turning

OHB’s Free Float Squeeze Nears a Release as KKR Exit and Rocket Flight Converge

Trending

Novo Nordisk Stock
Analysis

Novo Nordisk Sharpens Its Pipeline Edge as Longevity Pivot Takes Shape

by Rodolfo Hanigan
June 14, 2026
0

The Danish pharmaceutical heavyweight arrived at the American Diabetes Association congress in New Orleans armed with a...

BMW Stock

BMW Executive Puts Money on Recovery After Stock Plunge, as Electric M-Concept Unveiled at Le Mans

June 14, 2026
Uranium Energy Stock

Uranium Energy’s $52 Million Quarter: No Revenue, a New Texas Mine, and a $794 Million Cushion

June 14, 2026
Ocugen Stock

Ocugen Faces a Moment of Truth as Clinical Catalysts Collide With a 55% Plunge

June 14, 2026
Amazon Stock

Amazon’s Freight Gambit and Regulatory Headwinds Eclipse Prime Day Hype

June 14, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Novo Nordisk Sharpens Its Pipeline Edge as Longevity Pivot Takes Shape
  • BMW Executive Puts Money on Recovery After Stock Plunge, as Electric M-Concept Unveiled at Le Mans
  • Uranium Energy’s $52 Million Quarter: No Revenue, a New Texas Mine, and a $794 Million Cushion

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com